Clinical Trials Browser

Phase 2 × Quercetin × Head & Neck × Clear all

NCT05724329 2024-09-19

Neoadjuvant Tislelizumab in Combination With Dasatinib and Quercetin in Resectable HNSCC (COIS-01)

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT05456022 2022-07-13

Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line

Phase 2 Unknown

1,000,000 enrolled

Mouth Neoplasms